000 | 01471 a2200469 4500 | ||
---|---|---|---|
005 | 20250513042154.0 | ||
264 | 0 | _c19950615 | |
008 | 199506s 0 0 eng d | ||
022 | _a0268-3369 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRemberger, M | |
245 | 0 | 0 |
_aTNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD. _h[electronic resource] |
260 |
_bBone marrow transplantation _cJan 1995 |
||
300 |
_a99-104 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBone Marrow Transplantation |
650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft vs Host Disease _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aInterleukin-1 _xblood |
650 | 0 | 4 |
_aInterleukin-6 _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aNeoplasms _xblood |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
700 | 1 | _aRingden, O | |
700 | 1 | _aMarkling, L | |
773 | 0 |
_tBone marrow transplantation _gvol. 15 _gno. 1 _gp. 99-104 |
|
999 |
_c7742133 _d7742133 |